... ENG

AI Series

AI SERIES - AI assisted drug development and repurposing in Breast Cancer

With Dr. Evelyne Yehudit Bischof

Watch Now

AI Series

AI SERIES - Personalized vs precision medicine, clinical applicability

Presentation by Dr. Evelyne Yehudit Bischof

Watch Now

ASCO 2021 - CDK4/6 inhibition maintains improvements in survival with extended follow-up in advanced breast cancer

By oncoXchange | June 10th 2021

Read Now

AI Series

AI SERIES - Do we need Artificial Intelligence for Precision Medicine?

Presentation by Pr. Robert Clarke Ph.D., D.Sc.

Watch Now

AI Series

AI SERIES: Precision medicine in practice - diagnostic algorithms & geroncology

Presentation by Dr. Evelyne Yehudit Bischof

Watch Now

AI Series

AI SERIES - Precision medicine cancer therapeutics, HR sensitive BC and AI challenges

Presentation by Pr. John Robertson MD

Watch Now

ESMO 2021 - Immunotherapy, CDK4/6 inhibition shown to improve survival in advanced breast cancer

By oncoXchange | October 4th 2021

Read Now

ESMO 2021 - Immunotherapy but not PARP inhibitor improves outcomes when added to chemotherapy in early TNBC

By oncoXchange | September 21st 2021

Read Now

Load More